• Protecting the Supply: North America’s Next Generation of Strategic Mineral Leaders
    Jan 22 2026

    https://markets-headlines.com/wp-content/uploads/2026/01/Protecting-the-Supply-North-Americas-Next-Generation-of-Strategic-Mineral-Leaders-1.mp4

    The post Protecting the Supply: North America’s Next Generation of Strategic Mineral Leaders appeared first on markets-headlines.

    Mehr anzeigen Weniger anzeigen
    2 Min.
  • Infrastructure Pivot Unlocks Margin Expansion: Operational Grit Triggers 2026 Asset Re-Rating
    Jan 20 2026

    Issued on behalf of RUA GOLD Inc. VANCOUVER, BC, Jan. 20, 2026 — Equity Insider News Commentary – The global mining sector is undergoing a structural realignment as producer margins expand to record levels, with top-tier firms now reporting All-In Sustaining Costs (AISC) below $1,500 per ounce[1] while gold trades near historic $4,700 resistance. As […]

    The post Infrastructure Pivot Unlocks Margin Expansion: Operational Grit Triggers 2026 Asset Re-Rating appeared first on markets-headlines.

    Mehr anzeigen Weniger anzeigen
    2 Min.
  • Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
    Jan 16 2026

    Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Jan. 16, 2026 — Equity Insider News Commentary – The precision medicine sector is undergoing a structural realignment toward platform-based biologics, as the market prepares to surge from $138 billion this year to over $537 billion by 2035[1]. This shift marks the end of “one-size-fits-all” treatments, […]

    The post Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape appeared first on markets-headlines.

    Mehr anzeigen Weniger anzeigen
    2 Min.
  • Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
    Jan 14 2026

    Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Jan. 14, 2026 — Equity-Insider.com News Commentary – The precision oncology market is hitting a massive growth spurt, projected to rocket from $110 billion toward a staggering $225.65 billion by 2032[1]. This gold rush is accelerating as Big Pharma giants scramble to survive a looming $170 […]

    The post Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff appeared first on markets-headlines.

    Mehr anzeigen Weniger anzeigen
    2 Min.
  • Sovereign Defense Boom: The €381 Billion Shift to Local Military Tech
    Jan 12 2026

    Issued on behalf of VisionWave Holdings, Inc. VANCOUVER, BC, Dec. 24, 2025– Equity Insider News Commentary – European and NATO allies confirmed a credible pathway to achieving 5% GDP defense spending by 2035 at the December 3 NATO Foreign Ministers meeting, reinforcing the strategic imperative for Allied nations to localize military production and reduce reliance […]

    The post Sovereign Defense Boom: The €381 Billion Shift to Local Military Tech appeared first on markets-headlines.

    Mehr anzeigen Weniger anzeigen
    1 Min.
  • The New Arms Race: Investing in Speed, Agility, and Responsive Space Infrastructure
    Jan 11 2026

    Issued on behalf of Starfighters Space, Inc. Equity Insider News Commentary VANCOUVER, BC, Jan. 2, 2026 -Equity Insider- As global adversaries field operational hypersonic vehicles, the U.S. has reached a ‘Sputnik moment’ for tactical space access. With the Pentagon committing over $6.9 billion to hypersonic weapons development for FY 2025[1], the market is no longer […]

    The post The New Arms Race: Investing in Speed, Agility, and Responsive Space Infrastructure appeared first on markets-headlines.

    Mehr anzeigen Weniger anzeigen
    1 Min.
  • Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize
    Jan 11 2026

    Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Jan. 2, 2026 – Equity Insider News Commentary – The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that target genetic diseases at their source[1]. The FDA approved three transformative cell therapies this December alone, marking an […]

    The post Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize appeared first on markets-headlines.

    Mehr anzeigen Weniger anzeigen
    3 Min.